During the past decade, Sanatorio de La Providencia conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Sanatorio de La Providencia" are "Melanoma" (1 trials) and "Metastatic or Unresectable Cutaneous Melanoma" (1 trials). Many other conditions were trialed in "Sanatorio de La Providencia" in a lesser frequency.

Most popular intervention types in "Sanatorio de La Providencia" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "MEK162" (2 trials), "Dacarbazine" (1 trials), "LGX818" (1 trials) and "vemurafenib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sanatorio de La Providencia" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Sanatorio de La Providencia". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Sanatorio de La Providencia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sanatorio de La Providencia, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".